Guillen, Katrin P.
Fujita, Maihi
Butterfield, Andrew J.
Scherer, Sandra D. http://orcid.org/0000-0002-7943-8595
Bailey, Matthew H.
Chu, Zhengtao
DeRose, Yoko S.
Zhao, Ling
Cortes-Sanchez, Emilio
Yang, Chieh-Hsiang
Toner, Jennifer
Wang, Guoying
Qiao, Yi
Huang, Xiaomeng
Greenland, Jeffery A.
Vahrenkamp, Jeffery M.
Lum, David H. http://orcid.org/0000-0002-0159-8724
Factor, Rachel E.
Nelson, Edward W.
Matsen, Cindy B.
Poretta, Jane M.
Rosenthal, Regina
Beck, Anna C.
Buys, Saundra S.
Vaklavas, Christos
Ward, John H.
Jensen, Randy L.
Jones, Kevin B. http://orcid.org/0000-0003-1531-2157
Li, Zheqi
Oesterreich, Steffi http://orcid.org/0000-0002-2537-6923
Dobrolecki, Lacey E.
Pathi, Satya S.
Woo, Xing Yi
Berrett, Kristofer C.
Wadsworth, Mark E.
Chuang, Jeffrey H. http://orcid.org/0000-0002-3298-2358
Lewis, Michael T.
Marth, Gabor T.
Gertz, Jason
Varley, Katherine E.
Welm, Bryan E. http://orcid.org/0000-0002-1879-6612
Welm, Alana L. http://orcid.org/0000-0002-1412-1351
Article History
Received: 12 March 2021
Accepted: 12 January 2022
First Online: 24 February 2022
Competing interests
: University of Utah may license the models described herein to for-profit companies, which may result in tangible property royalties to members of the Welm lab who developed the models (K.P.G., M.F., A.J.B., S.D.S., Z.C., Y.S.D., L.Z., E.C.-S., C.-H.Y., J.T., G.W., A.L.W. and B.E.W.). M.T.L. is a Manager in StemMed Holdings LLC, a limited partner in StemMed Ltd, and holds an equity stake in Tvardi Therapeutics. L.E.D. is a compensated employee of StemMed, Ltd. S.O. has received research support/reagents from AstraZeneca, Illumina, H3 Biomedicine and Blueprint Medicine. The other authors declare no conflicts.